These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 6172172)

  • 1. The natural history of untreated "prostatism".
    Ball AJ; Feneley RC; Abrams PH
    Br J Urol; 1981 Dec; 53(6):613-6. PubMed ID: 6172172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostatism. I. The correlation between symptoms, cystometric and urodynamic findings.
    Andersen JT; Nordling J; Walter S
    Scand J Urol Nephrol; 1979; 13(3):229-36. PubMed ID: 93780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urodynamics in benign prostatic hyperplasia (BPH).
    Schäfer W
    Arch Ital Urol Androl; 1993 Dec; 65(6):599-613. PubMed ID: 7508790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urodynamics in prostatism. I. Prognostic value of uroflowmetry.
    Jensen KM; Jørgensen JB; Mogensen P
    Scand J Urol Nephrol; 1988; 22(2):109-17. PubMed ID: 2462745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential diagnosis of prostatism: A 12-year retrospective analysis of symptoms, urodynamics and satisfaction with therapy.
    Kaplan SA; Bowers DL; Te AE; Olsson CA
    J Urol; 1996 Apr; 155(4):1305-8. PubMed ID: 8632561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Contribution of pressure-flow relationship studies in the evaluation of benign hypertrophy of the prostate].
    Haab F
    Prog Urol; 1999 Feb; 9(1):151-5. PubMed ID: 10212970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Urodynamic study of obstructive uropathy due to benign prostatic hyperplasia].
    Fedel V; Povrzanović I; Fedel I
    Lijec Vjesn; 1992; 114(9-12):259-61. PubMed ID: 1285282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of presenting symptoms in prostatism.
    Frimodt-Møller PC; Jensen KM; Iversen P; Madsen PO; Bruskewitz RC
    J Urol; 1984 Aug; 132(2):272-6. PubMed ID: 6204066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multichannel urodynamic studies in men with benign prostatic hyperplasia. Indications and interpretation.
    Blaivas JG
    Urol Clin North Am; 1990 Aug; 17(3):543-52. PubMed ID: 1695781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of invasive urodynamic testing in benign prostatic hyperplasia and male lower urinary tract symptoms.
    Mehdizadeh JL; Leach GE
    Urol Clin North Am; 2009 Nov; 36(4):431-41, v. PubMed ID: 19942043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urodynamic results of laser treatment in patients with benign prostatic hyperplasia. Can outlet obstruction be relieved?
    de Wildt MJ; Te Slaa E; Rosier PF; Wijkstra H; Debruyne FM; de la Rosette JJ
    J Urol; 1995 Jul; 154(1):174-80. PubMed ID: 7539860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bladder outflow tract obstruction and urinary retention from benign prostatic hypertrophy treated by balloon dilatation.
    Gill KP; Machan LS; Allison DJ; Williams G
    Br J Urol; 1989 Dec; 64(6):618-22. PubMed ID: 2483354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association among the symptoms, quality of life and urodynamic parameters in patients with improved lower urinary tract symptoms following a transurethral resection of the prostate.
    Seki N; Yunoki T; Tomoda T; Takei M; Yamaguchi A; Naito S
    Neurourol Urodyn; 2008; 27(3):222-5. PubMed ID: 17580358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship of detrusor instability and symptoms with objective parameters used for diagnosing bladder outlet obstruction: a prospective study.
    Wadie BS; Ebrahim el-HE; Gomha MA
    J Urol; 2002 Jul; 168(1):132-4. PubMed ID: 12050506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology and differential diagnosis of benign prostatic hypertrophy.
    Blaivas JG
    Urology; 1988 Dec; 32(6 Suppl):5-11. PubMed ID: 2462303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of short-term overactive bladder symptom improvement after transurethral resection of prostate in men with benign prostatic obstruction.
    Zhao YR; Liu WZ; Guralnick M; Niu WJ; Wang Y; Sun G; Xu Y
    Int J Urol; 2014 Oct; 21(10):1035-40. PubMed ID: 24825248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precision of a patient-weighted symptom score in prostatism. The DAN-PSS-1 questionnaire.
    Brasso K; Stigsby B; Pilsgård B; Nordling J
    Scand J Urol Nephrol; 1994 Mar; 28(1):71-5. PubMed ID: 7516575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editorial comment on: Functional outcome following photoselective vaporisation of the prostate (PVP): urodynamic findings within 12 months follow-up.
    Bachmann A
    Eur Urol; 2008 Oct; 54(4):908-9. PubMed ID: 18502568
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial comment on: Functional outcome following photoselective vaporisation of the prostate (PVP): urodynamic findings within 12 months follow-up.
    Seitz M
    Eur Urol; 2008 Oct; 54(4):909-10. PubMed ID: 18502567
    [No Abstract]   [Full Text] [Related]  

  • 20. Editorial comment on: Functional outcome following photoselective vaporisation of the prostate (PVP): urodynamic findings within 12 months follow-up.
    Reich O
    Eur Urol; 2008 Oct; 54(4):908. PubMed ID: 18502566
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.